Company: BBVXF
Filing Date: 2025-02-14
Form Type: 6-K
Source: 0001193125-25-027343
Chunk: 12

Company: BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Filing Date: 2025-02-14
Form: 6-K
Chunk 12
---
 150% (maximum opportunity if all indicators reach their maximum level) 1,929 1,443 2023 Deferred AVR (€thousand, shares and stock options) Executive directors Maximum amount 2023 DAVR (STI + LTI 1) 2023 DAVR payable in 2025 2 (STI 1st payment—17.9% of the DAVR 1) 2023 DAVR payable in 2026 (STI 2nd payment—17.9% of the DAVR 1) 2023 DAVR payable each year in 2027, 2028 and 2029 (21.4% of the DAVR 1 each year) (LTI) Cash Shares Options Cash3 Shares Cash Shares Options Cash Shares Chair 1,202 189,802 189,609 215 38,821 215 11,862 189,609 257 46,373 CEO 899 141,955 141,809 161 29,034 161 8,872 141,809 192 34,683 This English version is a translation of the original in Spanish for information purposes only. In case of discrepancy the original in Spanish shall prevail.

Annual Report on the Remuneration of BBVA Directors 12 Second payment of the 2022 Deferred AVR (1) Second payment of the 2022 Deferred AVR for executive directors (20%). The remaining 60% will be deferred for payment, in equal parts, in 2026, 2027 and 2028, with these three payments being subject to the outcome of the multi-year performance indicators established for the 2022 Deferred AVR and any other ex post adjustments that may reduce the amount receivable. (2) This amount was updated in 2024 by applying the CPI in the amount of €7 thousand for the Chair and €5 thousand for the Chief Executive Officer. (3) This amount will be updated by applying the CPI in the amount of €13 thousand for the Chair and €10 thousand for the Chief Executive Officer. Third payment of the 2021 Deferred AVR (1) Third payment of the 2021 Deferred AVR for executive directors (20%). The remaining 40% is deferred for payment, in equal parts, in 2026 and 2027. (2) This amount was updated by applying the CPI in 2023, in the amount of €12 thousand euros